This article is current as at 29 April 2020

The European Parliament has voted to postpone the implementation deadline for MDR from May 2020 to May 2021. This gives a 12-month extension for those device manufacturers who have gotten caught in the middle. For our analysis on the extension click here.

Now that companies have a choice of MDD or MDR, and many companies are looking for emergency use reviews for their products, we cover who you can you go to for European registrations and provide corresponding contact information.

MDR ((EU) 2017/745) Certified Notified Bodies:

There is a total of 13 Notified Bodies certified for MDR. Interestingly, many of the already certified notified bodies have had revisions to their certifications. See below table including the latest MDR certification date:

IVDR ((EU) 2017/746) Notified Bodies:
Below is a table identifying the three notified bodies that are currently IVDR certified.

Pending Notified Bodies:
Although not extensive, this is a list of the notified bodies that have issued statements of their intention to apply for MDR and/or IVDR certification.

MDD (93/42/EEC MDD) Certified Notified Bodies:

Now that the MDR deadline has been moved 12-months and companies may be looking for an MDD certificate, below is the current distribution of MDD certified Notified Bodies:

IVDD (98/79/EC IVD) Certified Notified Bodies:

The IVDR implementation deadline is not due until 2022, so IVDD certifications are still very much in demand. Below is the distribution of total IVDD notified bodies:

Conclusions

In comparison to the original total number of MDD certified Notified Bodies of 126, only 13 have current MDR certification. This reflects how rushed the MDR transition was even before the COVID-19 Pandemic, given that the original deadline was scheduled for May 2020. Further for the IVDR, the number of Notified Bodies for IVDs is reflecting a similar lag from 39 original IVDD notified bodies to 3 IVDR certified bodies. To date, for both IVD and Medical Device Notified Bodies, about 10% of them have made the cut to certification under the new regulations.

The MDR extension is sure going to help. In terms of IVDs, Med Tech Europe has already started to request that the IVDR be delayed (Click here).

Overall, these transitions are never easy, but they are manageable. When the TGA transitioned to its version of IVDR some 5 years ago, there was certainly a lot of pain, and then the dust settled, and we got on our way. We expect the same to happen in Europe, albeit on a bigger scale and with much larger global implications.

Let’s not forget that CE Mark has been historically the passport for approvals in a majority of international markets.

Need Help?

Navigating the ever-changing world of Notified Bodies can be perplexing. If you are having issues, let us help. Reach out to initiate a conversation.

References:

European Commission Website: https://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=directive.main

Useful Link to Queries:
MDR Certified Notified Bodies: https://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=directive.notifiedbody&dir_id=34

IVDR Certified Notified Bodies: https://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=directive.notifiedbody&dir_id=35

MDD Certified Notified Bodies: https://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=directive.notifiedbody&dir_id=13

IVD D Certified Notified Bodies: https://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=directive.notifiedbody&dir_id=20

We offer deep support for navigating international regulatory processes. Whether it’s a TGA application, a strategy for MDR transition, a US presubmission or 510(k) filing, or specific help with regulatory documents (e.g. Clinical Evaluation Reports), or an update of your quality system to gain MDSAP. We understand you need a commercial approach which delivers viable options. Contact us to discuss your needs and how we can help. You can drop us an email [email protected] or call 1 888-271-5063 (US toll free) ♦ +61 2 9906 2984 (Sydney)

Disclaimer
The views and options expressed in this article are those of the author/s and do not necessarily reflect the views of Brandwood CKC Pty Ltd ACN 128 762 505.

The information presented in this article is of a general nature only and does not consider the particular circumstances of your business. Prior results and case studies do not guarantee a similar outcome in future. You should not rely on this information, and you should seek specific advice for your particular business needs.

Where indicated, certain content has been sourced from third parties; we have not independently verified it. Neither Brandwood CKC nor the author makes any warranty as to the accuracy, completeness or reliability of this article, nor do those parties accept any liability or responsibility arising in any way from omissions or errors contained in the content.